Steven R Hagen Insider Trading $AMRI ALBANY MOLECULAR RESEARCH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steven R Hagen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steven R Hagen. Steven R Hagen is Sr VP Pharmaceutical Dev & Mfg in ALBANY MOLECULAR RESEARCH INC ($AMRI).
Steven R Hagen in ALBANY MOLECULAR RESEARCH INC
Trading Symbol: AMRIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Steven R Hagen: Sr VP Pharmaceutical Dev & Mfg
Holdings: 34,330 shares
Current Value: $633,045
Latest Transaction: Mar 18 2014
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Steven R Hagen in ALBANY MOLECULAR RESEARCH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 254 | 0 | 34,330 | 34.6 K to 34.3 K (-0.73 %) |
Mar 12 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 254 | 0 | 34,584 | 34.8 K to 34.6 K (-0.73 %) |
Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | M | 2.93 | 2,500 | 7,325 | 25,000 | |
Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 15.19 | 2,500 | 37,975 | 34,838 | 37.3 K to 34.8 K (-6.70 %) |
Feb 25 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Buy | M | 2.93 | 2,500 | 7,325 | 37,338 | 34.8 K to 37.3 K (+7.18 %) |
Feb 27 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | M | 9.34 | 3,000 | 28,020 | 0 | |
Feb 27 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 15.73 | 3,000 | 47,190 | 34,838 | 37.8 K to 34.8 K (-7.93 %) |
Feb 27 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Buy | M | 9.34 | 3,000 | 28,020 | 37,838 | 34.8 K to 37.8 K (+8.61 %) |
Feb 24 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 14.87 | 1,500 | 22,305 | 34,838 | 36.3 K to 34.8 K (-4.13 %) |
Feb 19 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Sell | S | 13.37 | 1,500 | 20,055 | 36,338 | 37.8 K to 36.3 K (-3.96 %) |
Feb 19 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 1,038 | 0 | 37,838 | 38.9 K to 37.8 K (-2.67 %) |
Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Option Exercise | A | 10.43 | 25,000 | 260,750 | 25,000 | |
Feb 06 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Grant | A | 10.43 | 12,500 | 130,375 | 38,876 | 26.4 K to 38.9 K (+47.39 %) |
Feb 04 2014 | AMRI | ALBANY MOLECULAR R ... | Hagen Steven R | Sr VP Pharmaceutica ... | Payment of Exercise | F | 0.00 | 1,038 | 0 | 26,376 | 27.4 K to 26.4 K (-3.79 %) |
Page: 1